Jacob Hodskins, MD, MS - Owensboro Health

Skip to Content

Contact Information

Website: Cancer Care

A referral is required.

Locations

Jacob Hodskins

Jacob Hodskins, MD, MS

Specializing in Hematology & Oncology
  • One Health
Gender:
Male
Year joined staff:
2016

Languages

  • English

Education & Training

Education

1999-2003
Transylvania University, B.A., Biology, Psychology
2003-2005
University of Kentucky, M.S., Medical Sciences (Physiology)
2006-2010
University of Kentucky, M.D.

Residency

2011-2013
University of Kentucky Department of Internal Medicine, Internal Medicine

Fellowship

2013-2016
University of Kentucky Department of Hematology, Bone Marrow Transplantation & Medical Oncology (Chief Fellow 2015-2016)

Internships

2010-2011
University of Kentucky Department of Internal Medicine, Internal Medicine

Professional Memberships

  • American Society Clinical Oncology 2013-present
  • American Society of Hematology 2013-present
  • ACP of Kentucky Clinical Vignette Award (2012)
  • American College of Physicians (2010-present)
  • Kentucky Medical Association (2010-present)
  • Kentucky Medical Association Cancer Committee (2010)

Honors, Awards, etc.

  • General Clinical Research Center Mentored Student Award Grant (2008)
  • Dr. R. Todd and Patricia Sweeney Scholarship (2008)

Research Interest

  • Tumor genetic profiling and Genome directed cancer therapy
  • Lung cancer screening
  • Models of breast cancer prognosis and management

Publications

  • Comprehensive genomic profiling (CGP) at an NCI-designated cancer center reveals a high frequency of clinically relevant genomic alterations (CRGA) but identifies significant barriers to implementing genomically directed therapy (GDT).  ASCO epub 2016.
  • Hodskins JS, Fleischman R.  Ibrutinib-Associated Autoimmune Hemolytic Anemia. Blood 2014 124:5671.
  • Marty Driesler Lung Cancer Project: Cancer Incidence and Survival in Screened and Unscreened Populations. Markey Cancer Center Research Day 2014
  • Glioblastoma: Improving Therapy on a Formidable Disease.  Markey Cancer Center Affiliate Network Presentation 2014
  • Chen L, Romond E, Chokshi S, Saeed H, Hodskins J et al.  A prognostic model of early breast cancer relapse after standard adjuvant therapy and comparison with metastatic disease on initial presentation.  Breast Cancer Res Treat. 2012 Nov;136(2): 565-72
  • Aryal S, Hodskins JS, Adkins D.  Diffuse Alveolar Hemorrhage in a Patient with Hepatitis C.  Am J Respir Crit Care Med 185; 2012:A6168
  • Kasarskis EJ, Hodskins JS, St. Clair WH. Unilateral parotid electron beam radiotherapy as palliative treatment for sialorrhea in amyotrophic lateral sclerosis. J Neurol Sci. 2011 Sep 15;308(1-2); 155-7.
  • Hodskins JS, Kasarskis EJ. Effects of NIPPV on Energy Expenditure in ALS. 2007 Jul. (Completed/Accepted Research Protocol)
  • Sporici RA, Hodskins JS, Diamond SE, et al. Pit-1 B-domain Represses Anterior Pituitary Hormone Gene Expression. J Molecular Endocrinology. 2005 Oct; 35(2): 317-331.